Home » Topics » BioWorld

BioWorld
RSS

TREDEGAR INCREASES INVESTMENT IN CTA

Sep. 16, 1991

BAXTER ASKS COURT TO DISMISS LITIGATION

Sep. 16, 1991

IVAX PLANS TO ACQUIRE NOVEN PHARMACEUTICALS

Sep. 16, 1991

APPOINTMENTS AND ADVANCEMENTS

Sep. 16, 1991

ADVANCED CF TESTING SERVICE

Sep. 13, 1991

ALLIANCE FILES FOR 2 MILLION-SHARE OFFERING

Sep. 13, 1991

DIAGNOSTIC TO COMPLETE ACQUISITION

Sep. 13, 1991

SYNTHECELL 1st CLOSING RAISES $1 MILLION

Sep. 13, 1991

RIBI'S SELECTIVE IMMUNE STIMULANT

Sep. 13, 1991

ANALYSTS SPUR CENTOCOR, GI STOCK

Sep. 13, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...